COMPARISON OF INJECTION CARBETOCIN WITH INJECTION OXYTOCIN IN VAGINAL DELIVERY FOR PREVENTION OF BLOOD LOSS
Not Applicable
- Conditions
- Health Condition 1: O721- Other immediate postpartum hemorrhage
- Registration Number
- CTRI/2024/03/063466
- Lead Sponsor
- DATTA MEGHE INSTITUTE OF HIGHER EDUCATION AND RESEARCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
REPRODUCTIVE AGE GROUP AND ELIGIBLE FOR STUDY
SINGLETON PREGNANCY
TERM GESTATION
Exclusion Criteria
WOMEN WITH KNOWN COAGULOPATHY
STUDY DRUG HYPERSENSITIVITY
OLIGOHYDRAMNIOS OR POLYHYDRAMNIOS
CARDIAC DISEASES (INCLUDING DYSRHYTHMIA)
HYPERTENSION
LIVER,RENAL OR ENDOCRINE DISEASES (EXCEPT GESTATIONAL DIABETES)
UTERINE FIBROIDS OR SUSPICION OF PLACENTAL PATHOLOGY (ACRETA, PREVIA OR ABRUPTIO)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method INTRA-PARTUM BLOOD LOSS <br/ ><br>UTERINE TONETimepoint: 24 HOURS
- Secondary Outcome Measures
Name Time Method DIFFERENCE IN HEMOGLOBIN TAKEN BEFORE THE VAGINAL DELIVERY AND 48 HOURS AFTER VAGINAL DELIVERY <br/ ><br>NEED FOR ADDITIONAL UTEROTONICS <br/ ><br>EVALUATION OF NAUSEA AND VOMITINGTimepoint: 48 HOURS